688089.SHG Cabio Biotech Wuhan Co Ltd

Healthcare Biotechnology Shanghai Stock Exchange
7.73 CNY
Close of Nov 5, 2026
6.91 26.25
Market cap
CNY 1.29B
P/E
-
P/B
0.91x
ROE
-22.9%
Dividend yield
2.79%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 688089.SHG undervalued?

Graham number

The Graham number of Cabio Biotech Wuhan Co Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Cabio Biotech Wuhan Co Ltd fundamental analysis

No fundamental analysis for Cabio Biotech Wuhan Co Ltd yet.

Cabio Biotech Wuhan Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Cabio Biotech Wuhan Co Ltd

Cabio Biotech (Wuhan) Co., Ltd. engages in the research, development, production, and sale of functional ingredients and bio-based products in China and internationally. The company offers polyunsaturated fatty acids, including arachidonic acid (ARA) and docosahexaenoic acid (DHA); terpenoids, such as beta (ß)-carotene and astaxanthin; and carbohydrates, such as N-acetylneuraminic acid and human milk oligosaccharides. Its products are used in human nutrition, including early…

Full company profile